Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tuberous Sclerosis Complex
100%
Metastatic Renal Cell Carcinoma (mRCC)
71%
TSC1
26%
Clinical Benefit
21%
Targeted Therapy
20%
Clinical Features
19%
Epilepsy
19%
Rapalogs
17%
Neurodevelopmental Outcome
17%
Disease Transmission
17%
Disease Risk
17%
Ipilimumab
17%
Low-level Mosaicism
17%
Clinical Risk
17%
Mammalian Target of Rapamycin (mTOR)
16%
Metastatic RCC
15%
Epileptiform
14%
Autism Spectrum Disorder
13%
Sunitinib
13%
Pathogenic Variants
12%
Overall Survival
12%
95% Confidence Interval
11%
Clinical Database
11%
Everolimus
11%
In Cancer
11%
Seizure
11%
Neurodevelopment
11%
Electroencephalography
11%
Pathway Genes
11%
Renal Cell Carcinoma
11%
Adverse Events
10%
Electroencephalography Activity
10%
Prospective Cohort Study
10%
Middle East
10%
MTOR Inhibitor
10%
Survival Outcomes
9%
Epilepsy Outcome
8%
Single nucleotide Polymorphism
8%
Transmission Genetics
8%
Excel
8%
Fetal Brain Magnetic Resonance Imaging
8%
Signet Ring
8%
Leptomeningeal Carcinomatosis
8%
Poor Risk
8%
Variation Analysis
8%
Colorectal Adenocarcinoma
8%
Anti-PD-1 Therapy
8%
Melanoma Metastasis
8%
Early MRI
8%
Plasma Cell-free DNA
8%
Medicine and Dentistry
Kidney Metastasis
53%
Tuberous Sclerosis
26%
Malignant Neoplasm
22%
Ipilimumab
17%
Diseases
16%
Targeted Therapy
15%
Systemic Therapy
13%
Neoplasm
13%
Epilepsy
12%
Clinical Trial
12%
Breast Cancer
10%
Clear Cell Renal Cell Carcinoma
9%
Tyrosine-Kinase Inhibitor
9%
Overall Survival
9%
Magnetic Resonance Imaging
8%
Mammalian Target of Rapamycin
8%
Prevalence
8%
Mosaicism
8%
Epileptic Seizure
8%
Everolimus
8%
Cancer Treatment
8%
Metastatic Melanoma
8%
Tertiary Care
8%
Lenvatinib
8%
Glycon
8%
Programmed Death-Ligand 1
8%
Tumor Microcirculation
8%
Immune-Related Adverse Events
8%
Immunotherapy
8%
Colorectal Carcinoma
8%
Cancer Stem Cell
8%
PARP Inhibitor
8%
Nerve Cell Differentiation
8%
Tumor Cell
8%
DNA Methylation
8%
Immune-Related Gene
8%
Cancer Pathobiology
8%
Sprouting Angiogenesis
8%
Microcirculation
8%
Cell-Free DNA
8%
DNA Determination
8%
Erythrocyte
8%
Immune Checkpoint Inhibitor
7%
DNA Repair
6%
Meningeal Carcinomatosis
5%
Tumor Progression
5%
Progression Free Survival
5%
Methylated DNA Immunoprecipitation
5%
Clear Cell
5%